SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is gaining traction as community members highlight a relentless, organic push to build an ecosystem through diverse real-world initiatives and products. Investors are emphasizing a 'build-first' culture and consistent dollar-cost averaging as they look toward future scaling and long-term brand growth.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending as investors weigh strong revenue growth and bullish analyst sentiment against concerns regarding high short interest and upcoming lock-up expirations. The community remains deeply divided, with many traders anticipating a potential short squeeze around the next earnings report, while others caution that insider activity and valuation pressures could lead to further downside.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is attracting investor attention as the community pivots to focus on its role in building decentralized cloud infrastructure and AI-native applications rather than just speculative trading. Discussions are currently centered on its potential as a sovereign alternative to centralized hyperscalers, with sentiment split between long-term bulls highlighting infrastructure breakthroughs and skeptics concerned about price performance and tokenomics.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently in the spotlight due to high investor interest in its robust oncology pipeline, including the acquisition of Firefly Bio, and significant developments in its medical technology and autoimmune treatment portfolio. The community is actively weighing the long-term potential of these growth catalysts against ongoing litigation headwinds and broader defensive rotation within the healthcare sector.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing increased community chatter as investors digest recent institutional accumulation and corporate restructuring, even as the stock faces downward pressure from concerns over DefenCath's reimbursement transition. The community remains divided between long-term bulls highlighting strong institutional holdings and potential pipeline expansion, and skeptics wary of management's communication and recent performance trends.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma Inc. is trending as investors rally around the company's recent strategic CHIPS Act funding and the expansion of its technical team, which the community views as strong validation of its semiconductor platform. Sentiment is driven by high short interest and a growing conviction that its quantum-dot technology is positioned to solve critical data bottlenecks in AI infrastructure.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARK Innovation ETF is facing significant scrutiny and heavy selling pressure as retail investors vent frustration over its long-term underperformance and aggressive, volatility-heavy rebalancing strategy. While Cathie Wood continues to aggressively buy the dip in speculative growth and crypto-linked equities, the community remains deeply divided between those labeling the fund a value-destroying trap and those viewing its recent price levels as a potential entry point for long-term innovation exposure.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Investors are closely monitoring Celsius Holdings as short interest remains elevated ahead of upcoming second-quarter earnings, with the community debating whether current price levels represent an undervalued entry point or a broader fundamental decline. Despite ongoing volatility and bearish sentiment regarding competition and margin pressure, bulls are actively accumulating shares and highlighting strong brand growth as potential catalysts for a reversal.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is currently trending due to its recent milestone as the first mass-production deployment of an end-to-end autonomous driving platform compatible with both NVIDIA and Qualcomm chips, combined with active institutional accumulation and ongoing stock buybacks. The community is actively discussing the stock's potential to decouple from Chinese AV sector volatility, focusing on its global commercial expansion, strong strategic partnerships, and technical performance in urban driving competitions.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing intense community debate as investors weigh the potential of the new Goliath mainnet and institutional adoption against ongoing price volatility and recurring accusations of manipulation. While some users are actively staking to capitalize on high APRs, others remain skeptical, pointing to the lack of transparent partnerships and the token's prolonged downward trend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAbbott Laboratories leverages a diversified portfolio across medical devices and diagnostics, bolstered by its recent acquisition of Exact Sciences...

Should You Invest in Liquidia Corporation Stock Ahead of Q2 Earnings? 

LQDA heads into its Q2 earnings with Yutrepia driving growth, rising profitability and a self-funded pipeline as investors watch quarterly performance.

Johnson & Johnson Shares Edge Higher as $3.5B Biotech Moves Expand Oncology Pipeline

Johnson & Johnson (NYSE: JNJ) shares are edging higher on Friday as investors digest two major biotech pipeline moves.read more...

ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down

AbbVie tops Q2 earnings and revenue estimates on strong immunology drug sales, but a lower 2026 EPS outlook tied to the Apogee deal weighs on shares.

Should You Buy, Sell or Hold Merck Stock Ahead of Q2 Earnings?

MRK heads into Q2 earnings with acquisition costs, Keytruda strength and Gardasil challenges likely to shape results. Is the stock still worth holding?

Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Deals

Johnson & Johnson expands its biotech pipeline with Firefly Bio acquisition and a strategic partnership with Sail Biomedicines.read more...

Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Johnson & Johnson's RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

Johnson & Johnson's RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer Johnson & Johnson's RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) receives...

Futures Rise As Oil Drops, Bond Selling Slows, Meta Tumbles And Microsoft Soars

Futures Rise As Oil Drops, Bond Selling Slows, Meta Tumbles And Microsoft Soars

 Futures rebound (for now) following yesterday's Fed-induced meltdown as the market is clearly questioning Warsh's credibility and potential usage of non-standard tools to fight inflation, pushing the yield...

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation

Johnson & Johnson (NYSE: JNJ) today announced the successful completion of its acquisition of Firefly Bio, Inc., a biotechnology company advancing its proprietary Firelink degrader antibody conjugate (DAC) platform, for $1 billion in cash. The Firelink DAC platform expands Johnson & Johnsons...

$JNJ Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.27 down -0.87% YoY
• Reported revenue of $25.31B up 6.60% YoY
• Johnson & Johnson increased 2026 guidance with estimated reported sales of $101.1 billion at the midpoint and increased adjusted EPS guidance by $0.13 to $11.68 at the midpoint for fiscal 2026.

JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

JNJJohnson & Johnson

Fundamentals

Connect Stocktwits to ChatGPT

Latest JNJ News